Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)

Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Patrick P., Ventura Ferreira, Monica S., Rolles, Benjamin, Kirschner, Martin, Holtbernd, Florian, Tometten, Mareike, Brümmendorf, Tim H., Beier, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069391/
https://www.ncbi.nlm.nih.gov/pubmed/35540715
http://dx.doi.org/10.1002/ccr3.5766
_version_ 1784700420412669952
author Hess, Patrick P.
Ventura Ferreira, Monica S.
Rolles, Benjamin
Kirschner, Martin
Holtbernd, Florian
Tometten, Mareike
Brümmendorf, Tim H.
Beier, Fabian
author_facet Hess, Patrick P.
Ventura Ferreira, Monica S.
Rolles, Benjamin
Kirschner, Martin
Holtbernd, Florian
Tometten, Mareike
Brümmendorf, Tim H.
Beier, Fabian
author_sort Hess, Patrick P.
collection PubMed
description Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.
format Online
Article
Text
id pubmed-9069391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90693912022-05-09 Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1) Hess, Patrick P. Ventura Ferreira, Monica S. Rolles, Benjamin Kirschner, Martin Holtbernd, Florian Tometten, Mareike Brümmendorf, Tim H. Beier, Fabian Clin Case Rep Case Reports Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms. John Wiley and Sons Inc. 2022-05-05 /pmc/articles/PMC9069391/ /pubmed/35540715 http://dx.doi.org/10.1002/ccr3.5766 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Hess, Patrick P.
Ventura Ferreira, Monica S.
Rolles, Benjamin
Kirschner, Martin
Holtbernd, Florian
Tometten, Mareike
Brümmendorf, Tim H.
Beier, Fabian
Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title_full Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title_fullStr Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title_full_unstemmed Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title_short Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
title_sort effective treatment of advanced hodgkin lymphoma with a modified beacopp regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (hmsn1)
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069391/
https://www.ncbi.nlm.nih.gov/pubmed/35540715
http://dx.doi.org/10.1002/ccr3.5766
work_keys_str_mv AT hesspatrickp effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT venturaferreiramonicas effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT rollesbenjamin effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT kirschnermartin effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT holtberndflorian effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT tomettenmareike effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT brummendorftimh effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1
AT beierfabian effectivetreatmentofadvancedhodgkinlymphomawithamodifiedbeacoppregimenforapatientwithdemyelinatinghereditarymotorandsensoryneuropathytype1hmsn1

Ejemplares similares